Kim Mouridsen

Publications
  1. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.

    Emblem, K. E., Mouridsen, K., Bjornerud, A., Farrar, C. T., Jennings, D., Borra, R. J. H., Wen, P. Y., Ivy, P., Batchelor, T. T., Rosen, B. R., Jain, R. K. & Sorensen, A. G., 15-Apr-2013, In : Cancer Research. 73, 8, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. T-1- and T-2*-dominant extravasation correction in DSC-MRI: Part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients

    Emblem, K. E., Bjornerud, A., Mouridsen, K., Borra, R. J. H., Batchelor, T. T., Jain, R. K. & Sorensen, A. G., Oct-2011, In : Journal of Cerebral Blood Flow and Metabolism. 31, 10, p. 2054-2064 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy

    Emblem, K. E., Mouridsen, K., Bjornerud, A., Farrar, C. T., Jennings, D., Borra, R. J. H., Wen, P. Y., Ivy, P., Batchelor, T. T., Rosen, B. R., Jain, R. K. & Sorensen, A. G., Sep-2013, In : Nature Medicine. 19, 9, p. 1178-1183 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

ID: 122452712